EUVIMEDEUVIMED entdecken
Crossref

Discovery of Novel Inhibitors for WD Repeat‐Containing Protein 5 ( WDR5 )‐ MYC Protein–Protein Interaction

Wei Sun, Huaxing Yu, Jiuyong Ye, Luoheng Qin, Linli Wang, Hailu Yan, Zhimin Zhang, Alex Aliper, Feng Ren, Xiao Ding iD, Alex Zhavoronkov, Dongzhou Liu

Chemical Biology & Drug Design · 2025

DOI: 10.1111/cbdd.70129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2025. Verfasst von Wei Sun und 11 weiteren Autor:innen. Beteiligte Einrichtung: Huadong Medicine Company Limited, Hangzhou, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-myc, Intracellular Signaling Peptides and Proteins, Drug Discovery. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The WD Repeat‐Containing Protein 5 (WDR5) and MYC interaction is crucial for MYC‐mediated oncogenesis, yet effective therapeutic intervention remains challenging due to the limited efficacy of current treatments targeting WDR5. Herein, we report the discovery of novel WDR5‐MYC protein–protein interaction (PPI) inhibitors with improved potency and drug‐like properties by utilizing a generative chemistry platform along with a physics‐model‐based tool AlChemistry. Initially, three hits were identified with reasonable binding affinity for WDR5, and further refinement through detailed structural analysis led to the discovery of sub‐micromolar affinity compounds (compound 9c‐1 ), which are > 30‐fold better than reported inhibitors. These findings provide a promising starting point for targeting the WDR5‐MYC interaction in MYC‐driven cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-mycIntracellular Signaling Peptides and ProteinsDrug DiscoveryHumansProtein BindingStructure-Activity RelationshipMolecular Docking SimulationBinding Sites

Stichwörter der Autor:innen

MYCPPIWDR5generative chemistryphysics‐model‐based tool

Substanzen

Proto-Oncogene Proteins c-mycWDR5 protein, humanIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Huadong Medicine Company Limited, Hangzhou, China.
  • Insilico Medicine Shanghai Ltd., Shanghai, China.
  • Insilico Medicine AI Limited, Masdar City, UAE.

ORCID-Profile: Xiao Ding

Zitieren

APA

Sun, W., Yu, H., Ye, J., Qin, L., Wang, L., Yan, H., Zhang, Z., Aliper, A., Ren, F., Ding, X., Zhavoronkov, A., & Liu, D. (2025). Discovery of Novel Inhibitors for WD Repeat‐Containing Protein 5 ( WDR5 )‐ MYC Protein–Protein Interaction. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70129

Vancouver

Sun W, Yu H, Ye J, Qin L, Wang L, Yan H, et al. Discovery of Novel Inhibitors for WD Repeat‐Containing Protein 5 ( WDR5 )‐ MYC Protein–Protein Interaction. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70129

BibTeX
@article{Sun2025,
  author = {Sun, Wei and Yu, Huaxing and Ye, Jiuyong and Qin, Luoheng and Wang, Linli and Yan, Hailu and Zhang, Zhimin and Aliper, Alex and Ren, Feng and Ding, Xiao and Zhavoronkov, Alex and Liu, Dongzhou},
  title = {Discovery of Novel Inhibitors for WD Repeat‐Containing Protein 5 ( WDR5 )‐ MYC Protein–Protein Interaction},
  journal = {Chemical Biology & Drug Design},
  year = {2025},
  doi = {10.1111/cbdd.70129}
}
Kostenlos starten →